Introduction
============

*Staphylococcus aureus* causes a wide range of human diseases, including impetigo, cellulitis, food poisoning, toxic--shock syndrome, necrotizing pneumonia, endocarditis and sepsis ([@b33]; [@b13]). Decades of selective pressure with β-lactam antibiotics and close proximity of susceptible hosts have resulted in a high prevalence of methicillin-resistant *S. aureus* (MRSA) in hospitals worldwide ([@b9]; [@b13]). Although these factors logically explain the high incidence of hospital-associated MRSA infections, the molecular basis for the increased incidence and severity of community-acquired (or associated) MRSA (CA-MRSA) infections among healthy individuals remains incompletely defined ([@b9]; [@b10]; [@b35]; [@b20]; [@b39]; [@b53]). Recent studies indicate strains that are the leading causes of CA-MRSA disease in the United States, represented by pulsed-field gel electrophoresis (PFGE) types USA300-0114 ([@b35]; [@b20]; [@b25]; [@b15]) and USA400 ([@b8]; [@b2]; [@b35]; [@b1]), have enhanced virulence compared with leading causes of hospital infections (e.g. USA200) ([@b48]). In addition to their distinct PFGE profiles ([@b35]), these two CA-MRSA strains can be distinguished from one another and from other *S. aureus* strains on the basis of multilocus sequence typing (MLST or ST) and sequencing of the variable number tandem repeats in the staphylococcal protein A gene (*spa*); USA300-0114 is *spa*-type 1 ([@b46]) and multilocus sequence type ST8, while USA400 is ST1 ([@b17]). Both strains also have the type IV staphylococcal chromosomal cassette *mec* element, which is common among CA-MRSA but not typically found in hospital adapted nosocomial MRSA ([@b2]; [@b48]; [@b15]). In addition, each strain has one or more common names, such as Los Angeles County clone (LAC) or FPR3757 (sequenced strain) used for USA300-0114 ([@b48]; [@b15]), and MW2 for the prototype USA400 strain ([@b8]; [@b2]). Enhanced virulence of USA300-0114 (referred to herein as either LAC or USA300) and USA400 (referred to herein as MW2) is linked in part to their ability to circumvent killing by neutrophils and cause host cell lysis ([@b48]). It is likely that exoproteins (cell surface-associated and freely secreted proteins) produced by these strains are an important component of this enhanced virulence ([@b19]; [@b48]; [@b15]).

Secreted virulence proteins of *S. aureus* can be categorized based on proven or putative function. Cytolytic toxins, such as haemolysins (Hla, Hlb, HlgABC) and leukocidins (LukD/E and Panton--Valentine leukocidin, PVL), oligomerize to form pores on the cell surface ([@b51]; [@b5]). Destruction of leucocytes (especially neutrophils), which can be mediated by these toxins, is likely a key component of CA-MRSA pathogenesis. For example, PVL has high specificity for granulocytes and is linked by epidemiology to CA-MRSA disease ([@b31]), although our recent studies indicate the toxin has a limited role in virulence ([@b49]). Staphylococcal enterotoxins are secreted superantigens (SAg) that bind to major histocompatibility complex (MHC) class II proteins, resulting in CD4+ T-cell activation and immune modulation ([@b37]; [@b34]; [@b41]; [@b32]). *S. aureus* also secretes numerous proteases and lipases that degrade host components, and proteins that sequester antibody or inactivate antibiotics ([@b19]). As a step towards understanding the role played by *S. aureus* exoproteins in virulence, previous proteomics-based studies identified immunogenic proteins produced by strain COL ([@b50]), evaluated the role played by *S. aureus agr* and *sigB* on secretion of virulence factors ([@b55]), and tested the effects of linezolid on production of virulence factors ([@b4]). However, a comprehensive analysis of the exoproteins produced by CA-MRSA has not been conducted.

To that end, we used a proteomic approach to identify exoproteins of LAC and MW2 during growth *in vitro* and evaluated immunogenicity of the proteins using sera from mice infected with each strain. In addition, we used confocal microscopy to determine that selected exoproteins were produced within phagocytic vacuoles of human neutrophils following uptake, a phenomenon accompanied by host cell lysis.

Results
=======

Resolution and identification of culture supernatant proteins produced by CA-MRSA strains
-----------------------------------------------------------------------------------------

As an initial step towards gaining a comprehensive understanding of exoproteins made by the most prominent CA-MRSA strains, we resolved/identified proteins in MW2 (USA400) and LAC (USA300) culture supernatants using 2-dimensional gel electrophoresis (2-DGE) coupled with automated direct infusion-tandem mass spectrometry (ADI-MS/MS). Three hundred and fifty-three and 270 protein spots were resolved from MW2 and LAC culture media, respectively, at mid-exponential phase of growth ([Fig. 1A--D](#fig01){ref-type="fig"}). By comparison, 625 MW2 and 581 LAC proteins were resolved from culture supernatants at stationary phase of growth ([Fig. 1B](#fig01){ref-type="fig"}). Of the resolved exoproteins, 153 (60.2 ± 18%) from cultures at mid-exponential growth and 436 (67.9 ± 6.6%) from cultures at stationary growth matched between strains, indicating MW2 and LAC produce numerous proteins that co-migrate during 2-DGE ([Fig. 2](#fig02){ref-type="fig"}). We note that this analysis fails to account for variations of same or similar proteins with slightly different migration by 2-DGE. Therefore, our estimate of the degree of similarity between the two strains at the level of exoprotein (60% to 68%) is relatively conservative.

![Distribution and function of proteins found in MW2 and LAC culture supernatants. A. MW2 and LAC were cultured to mid-exponential (Mid-exp.) or stationary phases of growth as indicated, at which point proteins were identified/resolved using proteomics as described in *Experimental procedures*. B. Numbers in yellow-shaded regions represent proteins identified in both MW2 and LAC supernatants at the indicated growth phase. Numbers in red- or blue-shaded regions indicate proteins identified in MW2 or LAC supernatants respectively. Results are derived from three separate experiments. C. Proteins identified by ADI-MS/MS were categorized based upon functional annotation. Numbers are the per cent of total proteins identified. D. Proteins identified at mid-exponential and stationary phases of growth were enumerated and categorized by functional annotation. Carb. Met., carbohydrate transport and metabolism; AA Met., amino acid transport and metabolism; Vir. & Def., virulence and defence mechanisms; Toxins & Hem., toxins and haemolysins; Stress Resp., stress response; Cell Div., cell division and maintenance; Prot. Synth., protein synthesis; Nuc. Biosynth., nucleotide biosynthesis; FA Biosynth., fatty acid biosynthesis; Trans. & Rep., transcription and replication.](cmi0009-1172-f1){#fig01}

![2-DGE analyses of culture supernatant proteins produced by MW2 and LAC. Proteins from MW2 (green) and LAC (magenta) culture supernatants were analysed by proteomics. Left panel, proteins from cultures at mid-exponential (Mid-exp.) phase of growth. Right panel, proteins from cultures at stationary (Stat.) phase of growth. White areas are regions of overlap. Selected proteins are indicated. Images are representative of three separate experiments.](cmi0009-1172-f2){#fig02}

Using ADI-MS/MS and excluding protein isoforms and identifications from multiple gels, we identified 250 unique proteins from MW2 and LAC culture supernatants at the two phases of growth combined (98 at mid-exponential phase of growth and 228 at stationary phase) ([Fig. 2](#fig02){ref-type="fig"} and [Table 1](#tbl1){ref-type="table"}). Proteins were separated into categories based on functional annotation to facilitate subsequent analyses ([Fig. 1B and C](#fig01){ref-type="fig"}, and [Table 1](#tbl1){ref-type="table"}).

###### 

MW2 and LAC culture supernatant proteins identified by ADI-MS/MS.

  Protein name (Entrez protein name)[a](#tf1-1){ref-type="table-fn"}                 Entrez protein[a](#tf1-1){ref-type="table-fn"}   MW^E^    pI^E^   MP   SC%   MS/MS MOWSE score
  ---------------------------------------------------------------------------------- ------------------------------------------------ -------- ------- ---- ----- -------------------
  Carbohydrate transport and metabolism (61)                                                                                                                      
   Acetate kinase (AckA)^C1,D1^                                                      13701506                                         44029    5.7     10   31    226
   Acetoin reductase (ButA)^D2^                                                      49482369                                         27199    5.0     3    15    104
   Aconitate hydratase (AcnA)^B1,C1,D1^                                              49241672                                         98850    4.9     24   34    878
   Adenylate kinase (Adk)^B1,D2^                                                     49484445                                         23959    4.8     6    29    245
   Adenylosuccinate synthetase, putative (PurA)^C1^                                  49482270                                         47522    5.1     4    12    146
   Alcohol dehydrogenase (Adh)^B5,D6^                                                14246373                                         36039    5.5     13   45    558
   Alcohol dehydrogenase, zinc-containing (AdhE)^D1^                                 87162223                                         36244    5.3     4    13    93
   Aldehyde dehydrogenase (AldA1)^B1,D1^                                             49242475                                         51936    5.1     7    19    179
   ATP synthase beta chain (AtpD)^A1,C2,D1^                                          49484327                                         51368    4.7     4    11    101
   ATP synthase alpha chain (AtpA)^D1^                                               49484329                                         54550    4.9     4    9     82
   Citrate synthase II (GltA)^B2,C1,D2^                                              49483937                                         42566    5.4     14   50    507
   CoA synthetase protein, putative (FadE)^B1,C1,D1^                                 49483408                                         42060    4.9     9    23    256
   Deoxyribose-phosphate aldolase (Dra)^B1^                                          14247910                                         23327    4.7     3    17    56
   Dihydrolipoamide acetyltransferase: subunit E2 (PdhC)^A2,C2,D2^                   581570                                           46411    4.9     16   46    817
   Dihydrolipoamide dehydrogenase: subunit E3 (PdhC)^A2,B2,C1,D2^                    48874                                            49421    5.0     16   46    803
   Phosphoglycerate mutase (Gpm)^B2^                                                 14246544                                         56419    4.7     12   29    590
   Enolase (Eno)^A2,B3,C2,D4^                                                        6015099                                          47088    4.5     18   54    1257
   Methylenetetrahydrofolate dehydrogenase (FolD)^B2,D1^                             49244345                                         30824    5.4     13   68    859
   Formate tetrahydrofolate ligase (Fhs)^B1,C1,D1^                                   83288210                                         59876    5.8     16   44    759
   Formate acetyltransferase (PflB)^D2^                                              49482458                                         84808    5.3     6    11    193
   Fructose bisphosphate aldolase class I (Fba)^A1,B4,C2,D6^                         88196553                                         33034    4.9     14   57    683
   D-Fructose 6-phosphate amidotransferase (GlmS)^D1^                                49484376                                         65839    4.9     6    15    151
   6-Phospho-beta-galactosidase (LacG)^A1^                                           644835                                           116131   5.3     1    1     42
   Glucose 6-phosphate isomerase A (GpiA)^A1,B1,C1,D1^                               49244181                                         49777    4.8     20   53    1008
   Glucose 6-phosphate 1-dehydrogenase (Zwf)^D1^                                     49483755                                         56929    5.3     7    15    227
   Glyceraldehyde 3-phosphate dehydrogenase 1 (Gap)^A2,B5,C3,D5^                     49244087                                         36258    4.9     13   47    770
   Glyceraldehyde 3-phosphate dehydrogenase subunit B (GapB)^D1^                     38195941                                         36899    6.0     4    14    106
   Glyceraldehyde 3-phosphate dehydrogenase subunit C (GapC)^C1,D1^                  38195943                                         36227    4.9     3    10    65
   Glycerate dehydrogenase (MW2224)^B1,D2^                                           14248079                                         34681    5.1     10   41    377
   Glycine cleavage system H protein (GcvH)^A1,C1,D2^                                49241194                                         14072    4.0     2    30    194
   Glycine C-acetyltransferase, similar to (MW0505)^D1^                              14246318                                         41426    5.3     2    5     58
   Hexulose 6-phosphate synthase, putative (SgaH)^B1,D1^                             87160968                                         22404    4.6     12   81    656
   Hydrolase (HAD superfamily) (MW0575)^B1,D1^                                       49241218                                         27962    4.5     4    16    67
   Indole-3-pyruvate decarboxylase, putative (IpdC)^D1^                              14245955                                         60490    5.1     1    2     59
   Isocitrate dehydrogenase (Idh)^B1,D1^                                             49244963                                         46408    4.9     4    10    129
   L-Lactate dehydrogenase 1 (Ddh)^B3,D4^                                            57286685                                         34562    5.0     10   34    368
   Malate:quinone oxidoreductase (Mqo2)^A1,B1,C1,D1^                                 21205698                                         55892    6.2     7    17    301
   Mannitol-1-phosphate 5-dehydrogenase (MtlD)^B3,D1^                                49242510                                         40801    5.0     10   36    357
   2-C-Methyl-D-erythritol 4-phosphate cytidylyltransferase (IspDF)^B1^              49482491                                         26640    5.4     3    12    77
   NAD-dependent dehydrogenase, putative (MW2068)^B2^                                49245380                                         24057    5.0     15   81    643
   Oxoglutarate dehydrogenase (Ogdh)^B1,D1^                                          21204471                                         105289   5.4     14   22    401
   Phosphate acetyltransferase, putative (Pta)^A1,B4,C1,D5^                          22212856                                         20383    4.8     8    44    523
   Phosphoenolpyruvate carboxykinase (PckA)^B1,D1^                                   49484033                                         59370    5.7     20   44    678
   Phosphogluconate dehydrogenase (Pgd)^A1,C1,D1^                                    14247282                                         51751    5.1     5    15    122
   Phosphopentomutase, putative (Drm)^A1,B1,C2,D2^                                   14246544                                         56419    4.7     14   36    672
   Phosphoenolpyruvate-protein phosphatase (PtsI)^B1,D1^                             1070386                                          63179    4.7     12   22    490
   6-Phosphofructokinase (PfkA)^B2,D1^                                               49244967                                         34818    5.6     11   34    327
   6-Phosphogluconate dehydrogenase, decarboxylating (Gnd)^B1,D2^                    49483761                                         51770    5.0     12   30    564
   Phosphoglycerate kinase (Pgk)^A1,B2,C3,D2^                                        49483031                                         42575    5.2     14   47    615
   1-Pyrroline-5-carboxylate dehydrogenase (RocA)^B1,D1^                             21205647                                         56833    5.0     16   39    687
   Pyruvate carboxylase, putative (PycA)^B1,D1^                                      49483277                                         128451   5.2     14   14    353
   Pyruvate dehydrogenase E1 component, alpha subunit, putative (PdhA)^A1,C2^        49244374                                         41357    4.9     7    32    239
   Pyruvate dehydrogenase E1 component, beta subunit, putative (PdhB)^A2,B4,C1,D3^   57285889                                         35194    4.7     10   43    525
   Pyruvate kinase (Pyk)^A1,B2,C3,D1^                                                49242068                                         63103    5.2     18   38    610
   Short chain dehydrogenase MW2249 (MW2249)^D3^                                     21205420                                         31769    4.6     4    12    179
   Succinyl-CoA synthetase (SucD)^B1^                                                49244528                                         31506    5.5     5    25    154
   Succinyl-CoA synthetase (SucB)^D3^                                                49483408                                         42060    4.9     7    18    246
   Tagatose-bisphosphate aldolase, putative (LacD1)^A1,B6^                           49245361                                         30817    5.0     8    40    371
   Transaldolase, putative (MW1721)^B4,D2^                                           14247553                                         25742    4.8     7    37    273
   Transketolase (Tkt)^B1,D1^                                                        57284532                                         72206    5.0     19   35    703
   Triosephosphate isomerase (Tpi)^A1,B3,C2,D3^                                      49483032                                         27245    4.8     8    39    477
  Amino acid transport and metabolism (12)                                                                                                                        
   Alanine dehydrogenase 2 (Ald2)^D1^                                                49244722                                         40209    5.2     6    18    173
   Amidophosphoribosyltransferase precursor, putative (PurF)^B1^                     49244352                                         54363    6.1     12   23    426
   Cysteine synthase (CysK)^C2^                                                      82750220                                         32969    5.4     8    52    273
   3-Deoxy-7-phosphoheptulonate synthase (MW1680)^B1,D1^                             49483977                                         40609    5.8     7    24    229
   Glucosamine-fructose 6-phosphate aminotransferase (GlmS)^D1^                      14247927                                         65795    4.9     5    11    110
   Glutamine synthetase (GlnA)^B1^                                                   1134886                                          50808    5.1     11   34    400
   Imidazolonepropionase (HutI)^D1^                                                  87162411                                         45011    5.2     5    15    101
   Phosphoribosylformylglycinamidine synthase I (PurQ)^B1^                           14246838                                         24541    5.0     3    21    108
   Phosphotransferase system enzyme IIA-like protein (SH1484)^D1^                    88195154                                         17949    4.5     4    33    144
   SNO glutamine amidotransferase family protein (MW0475)^D1^                        49482749                                         20617    5.7     6    43    211
   Thiamine pyrophosphate enzyme, putative (MW0162)^B1,D1^                           49240559                                         60503    5.0     6    13    181
   Urocanate hydratase (HutU)^C1^                                                    14248105                                         60626    5.2     4    12    55
  Virulence/defence mechanisms (31)                                                                                                                               
   Aminopeptidase PepS (PepS)^D1,S^                                                  87161826                                         46805    4.8     8    19    226
   Aureolysin (Aur)^C1,D1,S^                                                         6119705                                          56281    5.1     3    8     102
   Chitinase (MW0945)^D1,S^                                                          49483226                                         11338    6.6     2    32    75
   Coagulase (Coa)^A4,C7,D1,S^                                                       46540                                            71675    8.4     20   37    920
   Collagen adhesin precursor (Cna)^A2,B1,L,M,S^                                     21205785                                         132921   5.9     7    7     199
   Ear (Ear)^B1,D1,M,S^                                                              21203924                                         20322    8.6     4    19    115
   Esterase\\lipase (MW2501)^B1,D2,S^                                                14248355                                         30986    4.7     10   52    415
   Fibrinogen-binding protein-related (MW1037)^A1,C1,S^                              49244435                                         12171    10.4    3    27    115
   FmtB protein (FmtB)^A1,D1^                                                        14247939                                         263611   4.6     9    4     229
   Fibronectin-binding protein A (FnbA)^C3,L,M,S^                                    87161146                                         111642   4.6     9    13    254
   Fibronectin-binding protein B (FnbB)^A1,B2,C2,L,M,S^                              87162339                                         103492   4.7     9    12    265
   IgG-binding protein (Sbi)^A2,S^                                                   49245643                                         50099    9.4     11   26    330
   IgG-binding protein A precursor (Spa)^A9,C7,D4,L,M,S^                             83682325                                         49338    5.7     16   45    666
   Lipase (Lip)^C3,D8,S^                                                             1095875                                          76845    7.1     19   30    947
   Lysophospholipase, putative (MW1732)^D1,S^                                        87162009                                         31019    5.1     9    53    306
   Metallo-beta-lactamase superfamily protein (YycJ)^B1,S^                           49483948                                         25306    5.0     4    24    101
   Mrp protein (Mrp)^C1^                                                             5834649                                          262876   4.6     9    4     250
   1-Phosphatidylinositol phosphodiesterase (Plc)^B1,D3,S^                           1172527                                          35213    6.5     13   52    452
   Putative sulfatase (MW0681)^B1,C1,D2,M,S^                                         49244034                                         74353    9.0     8    17    349
   SspA, V8 protease (SspA)^B2,D4,S^                                                 12025238                                         36304    5.0     6    27    337
   SspB, cysteine protease precursor (SspB)^A1,B3,C2,D9,S^                           12025239                                         44491    5.7     15   44    738
   Serine protease SplC (SplC)^B1,D2,S^                                              88195634                                         26082    6.3     7    27    212
   Staphylokinase precursor (Sak)^B4,C1,D6,S^                                        21205055                                         18483    6.8     7    67    411
   Succinyl-diaminopimelate desuccinylase (MW1943)^B1^                               13701801                                         45109    4.6     6    16    158
   Tetracycline resistance protein (TetP)^B1,M,S^                                    6094458                                          72677    5.3     1    2     60
   ThiJ/PfpI family protein, protease 1 (MW1815)^B3,D2^                              49240910                                         32171    5.0     6    67    323
   Trigger factor (prolyl isomerase) (Tig)^A2,B3,C2,D2^                              49483918                                         48565    4.3     8    24    439
   Tripeptidase, similar to (MW1465)^B1^                                             14247283                                         40172    5.0     4    12    88
   Truncated MHC class II analogue protein (SAOUHSC 02466)^D4^                       88196118                                         15438    8.7     7    55    300
   Xaa-His dipeptidase (MW1694)^B2,C1,D1,S^                                          49245019                                         52775    4.6     13   34    535
   Xaa-Pro dipeptidase (MW1482)^B1,D3,S^                                             49483779                                         39357    5.2     9    32    314
  Toxins and haemolysins (7)                                                                                                                                      
   Alpha-haemolysin, chain G (Hla)^C3,D4,S^                                          2914575                                          33227    7.9     14   51    666
   Enterotoxin C3 (Sec3)^B4,S^                                                       295149                                           27634    7.2     17   58    799
   Enterotoxin H (Seh)^B4,S^                                                         9955226                                          25128    5.2     7    38    282
   Enterotoxin K (Sek)^C1,D2,S^                                                      87161791                                         27733    8.3     6    25    252
   Enterotoxin L, extracellular (Sel2)^D2,S^                                         14247781                                         27479    9.0     2    4     83
   Enterotoxin Q (Seq)^B2,C2,D2,S^                                                   87161054                                         28129    7.7     8    43    358
   Exotoxin (SAUSA300_0407)^C1,S^                                                    88194194                                         25350    8.5     2    15    96
  Stress response proteins (20)                                                                                                                                   
   Alkaline shock protein 23 (Asp23)^A1,B7,C5,D11^                                   49484402                                         19180    5.1     8    60    301
   Alkyl hydroperoxide reductase subunit C (AhpC)^A1,B2,C2,D4^                       49482631                                         20963    4.9     7    53    514
   Alkyl hydroperoxide reductase subunit F (AhpF)^B1,D1^                             14246148                                         54674    4.7     5    11    164
   ATP-dependent Clp proteinase chain (ClpP)^B2,D3,M^                                14248322                                         77810    4.8     25   49    1416
   Catalase (KatA)^B1,C1,D2^                                                         7161887                                          58287    5.3     15   31    680
   Chaperone protein DnaK, HSP70 (DnaK)^A2,B1,C2,D,M^                                1169381                                          66307    4.6     15   34    875
   Chaperone protein HchA, Hsp31 (HchA)^B1^                                          49240910                                         32171    5.0     4    14    147
   Cold shock protein (CspA)^B2,C2,D2^                                               49483592                                         7317     4.5     3    78    188
   General stress protein 26 (MW2302)^B1,D1^                                         49245607                                         15807    5.1     4    40    199
   GroES (GroES)^D1^                                                                 18028156                                         10453    5.1     2    26    68
   NAD(P)H-flavin oxidoreductase, similar to (Frp)^D1^                               14248297                                         25359    5.5     4    17    56
   Nitric oxide dioxygenase (MW0216)^D1^                                             14246007                                         42932    5.2     4    12    104
   OsmC-like protein (MW0781)^B3,D1^                                                 49244117                                         15320    4.8     3    25    113
   Peroxiredoxin reductase (AhpF)^D1^                                                49243746                                         11325    6.4     3    42    67
   SrrA (SrrA)^D1^                                                                   37781574                                         28143    5.2     6    30    288
   Superoxide dismutase (SodA)^A1,B2,C1,D2^                                          49483802                                         22697    5.1     6    45    303
   Thioredoxin (TrxA)^B1,D2^                                                         49483308                                         11433    4.4     5    56    223
   Thioredoxin (MW1870)^B1,D1^                                                       49484170                                         21902    5.2     7    37    259
   Thioredoxin reductase (TrxB)^B1,C1,D2^                                            32468851                                         33595    5.2     9    30    456
   Universal stress protein, putative (MW1653)^B1,D5^                                49483951                                         18463    5.6     8    63    497
  Cell division and maintenance (33)                                                                                                                              
   Aminoglycoside phosphotransferase (AphA)^C1^                                      11991167                                         30624    4.5     3    16    64
   Autoinducer-2 production protein (LuxS)^D1^                                       49484358                                         17502    5.4     4    23    140
   Autolysin (Atl)^A2,B1,C3,D4,S^                                                    14248419                                         69186    6.0     20   43    867
   Cyclophilin type peptidyl-prolyl *cis*-*trans* isomerase, putative (MW0836)^D1^   49483114                                         21605    4.6     4    18    108
   Cell division initiation protein DivIVA (MW1335)^B1,D1^                           49483601                                         29963    4.4     3    11    114
   Cell division protein FtsZ (FtsZ)^A1,B1,D2^                                       38604824                                         41413    5.0     5    15    167
   Cytosol aminopeptidase family protein (PepA)^D1^                                  49483102                                         54140    5.7     9    23    215
   GAF domain protein (MW1661)^D1^                                                   88195528                                         17100    4.9     3    22    93
   HMG-CoA synthase (MvaS)^B3,D1^                                                    9937361                                          43191    5.0     10   31    414
   Histidine-containing phosphocarrier protein (PtsH)^D2^                            46908                                            9505     4.4     2    27    109
   Ferritin (Ftn)^B3,D7^                                                             49242263                                         19590    4.7     6    31    450
   Putative non-haem iron-containing ferritin (MW2063)^D2^                           49484363                                         16681    4.6     2    19    120
   Formylmethionine deformylase homologue (Def)^D1^                                  14246861                                         20546    5.8     6    38    111
   Fumarylacetoacetate (FAA) hydrolase family protein (Faa)^B1^                      49244187                                         33093    4.8     3    13    72
   Methionine aminopeptidase (Map)^D1^                                               49484129                                         27485    5.2     3    14    105
   Malonyl CoA-acyl carrier protein transacylase (FabD)^D1^                          14247000                                         33628    4.9     5    23    109
   Manganese-dependent inorganic pyrophosphatase (PpaC)^A1,C1,D1^                    492245182                                        34279    4.7     6    23    199
   Monofunctional biosynthetic peptidoglycan transglycosylate (MW1814)^D1^           49483860                                         11941    3.9     2    10    84
   Naphthoate synthase (MenB)^D1^                                                    14246815                                         30392    5.4     6    18    162
   Peptidoglycan hydrolase (LytM)^C2,S^                                              2239274                                          35147    6.1     4    20    207
   Putative 3-methyl-2-oxobutanoate hydroxymethyltransferase (PanB)^D1^              49245819                                         29237    5.6     8    30    348
   Secretory antigen precursor SsaA (SsaA)^D1^                                       87159889                                         17388    5.8     1    9     73
   Stage V sporulation protein (SpoVG)^B1^                                           13700388                                         12312    4.9     3    33    62
   tRNA, Arginyl-tRNA synthetase (ArgS)^B1,D1^                                       49240966                                         62312    5.1     7    16    220
   tRNA, Aspartyl-tRNA synthetase (AspS)^D1^                                         49483875                                         66527    5.0     10   17    163
   tRNA, Cysteinyl-tRNA synthetase (CysS)^D1^                                        46395518                                         53651    5.3     9    23    280
   tRNA, Glutamyl-tRNA amidotransferase subunit B (GatB)^C1,D3^                      82751553                                         53607    5.1     9    24    229
   tRNA, Glycyl-tRNA synthetase (GlyS)^D1^                                           49483813                                         53586    5.0     4    8     107
   tRNA, Isoleucyl-tRNA synthetase (IleS)^D1^                                        49244476                                         104825   5.3     8    10    179
   tRNA, Leucyl-tRNA synthetase (LeuS)^B1,D1^                                        21204871                                         91926    5.0     9    17    343
   tRNA, Phenylalanyl-tRNA synthetase beta subunit (PheT)^C1,D1^                     14246909                                         88885    4.7     9    13    317
   tRNA, Seryl-trna synthetase (SerS)^B1,D1^                                         14245776                                         48609    5.0     10   27    327
   tRNA, Threonyl-tRNA synthetase 1 (ThrS)^C1,D1^                                    14247455                                         74341    5.3     11   20    281
  Protein synthesis (18)                                                                                                                                          
   Acetyltransferase (GNAT) family protein (MW2324)^D2^                              49483339                                         16991    4.9     5    32    174
   Aminotransferase, putative (RocD)^B1,C1^                                          492241363                                        54376    6.1     7    19    229
   Branched-chain amino acid aminotransferase (IlvE)^D1^                             82750262                                         40061    5.0     5    20    220
   Deblocking aminopeptidase, similar to (MW1253)^D1^                                49483560                                         37848    5.3     1    3     58
   Formiminoglutamase (HutG)^D1^                                                     87160628                                         34491    5.4     6    29    223
   Glutamine ammonia ligase (GlnA)^A1,C1,D1^                                         14247080                                         50822    5.1     9    34    314
   30S Ribosomal protein S1 (RpsA)^A1,B1,C1,D2^                                      14247247                                         43283    4.6     15   51    740
   30S Ribosomal protein S2 (RspB)^B2,C1,D1^                                         57286011                                         29377    5.3     7    26    306
   30S Ribosomal protein S6 (RpsF)^A1,B2,C2,D3^                                      49482595                                         11588    5.1     6    58    268
   S30EA Family ribosomal protein, putative (MW0714)^B1,D2^                          49244067                                         22199    5.2     5    31    211
   50S Ribosomal protein L7/L12 (RplL)^A2,B2,C2,D4^                                  88194302                                         12704    4.6     7    72    352
   50S Ribosomal protein L10 (RplJ)^B1,C1,D1^                                        49243847                                         17672    4.8     5    51    242
   50S Ribosomal protein L25 (RplY)^C1^                                              49243808                                         23773    4.4     4    23    74
   O-acetylserine (thiol)-lyase, putative, cysteine synthase (CysK)^B2,C1,D2^        49243820                                         32955    5.4     11   58    500
   Ornithine aminotransferase (RocD1)^B1,D3^                                         49483117                                         43444    5.4     11   31    543
   Secretory antigen precursor (SsaA)^C3^                                            49242648                                         16997    5.8     1    9     86
   Secretory antigen precursor SsaA (MW0627)^C1^                                     49243980                                         28155    6.1     3    14    69
   Serine hydroxymethyltransferase (GlyA)^B1,D1^                                     49245349                                         45144    5.8     10   29    422
  Nucleotide biosynthesis (16)                                                                                                                                    
   Adenylosuccinate lyase (PurB)^D1^                                                 49484149                                         49572    5.6     7    18    154
   Adenylosuccinate synthase (PurA)^B1,D2^                                           49482270                                         47522    5.1     5    14    217
   Amidophosphoribosyltransferase precursor (PurF)^B1,D2^                            49244352                                         54363    6.1     12   23    426
   Carbamoyl-phosphate synthase large chain (CarB)^C1^                               14246973                                         117098   4.9     3    3     54
   GMP synthase (GuaA)^D2^                                                           38372353                                         58149    4.9     6    13    200
   Inositol-monophosphate dehydrogenase (GuaB)^A1,B1,C1,D1^                          21203531                                         52790    5.6     10   35    338
   Phosphoribosylamine-glycine ligase (PurD)^D1^                                     14246844                                         41946    5.0     2    6     50
   Phosphoribosylaminoimidazole-succinocarboxamide synthase (PurC)^B1,D1^            88194764                                         26676    5.3     12   62    494
   Phosphoribosylformylglycinamidine cyclo-ligase (PurM)^D2^                         14246841                                         36966    4.8     7    26    252
   Phosphoribosylformylglycinamidine synthetase (PurL)^B1,D1^                        14246839                                         79513    4.8     10   16    245
   Phosphoribosylformylglycinamidine synthase (PurS)^D2^                             14246838                                         24541    5.0     7    43    215
   Phosphoribosylformylglycinamidine synthase, PurS component (MW0950)^B2^           49241360                                         9929     4.7     4    68    225
   Polyribonucleotide nucleotidyltransferase (PnpA)^B1,D1^                           49244556                                         77342    4.9     14   23    530
   Purine nucleoside phosphorylase (DeoD1)^A1,B3,D2^                                 49484362                                         25892    4.9     6    35    329
   Pyridoxine biosynthesis protein (MW0474)^A1,C1,D1^                                49482748                                         31972    5.1     8    31    267
   Uracil phosphoribosyltransferase (Upp)^D1^                                        49484336                                         23035    6.1     9    58    496
  Fatty Acid Biosynthesis (1)                                                                                                                                     
   Trans-2-enoyl-ACP reductase (FabI)^B1,D1^                                         56001093                                         24601    5.2     7    53    226
  Transcription and Replication (18)                                                                                                                              
   2′−5′ RNA ligase (MW0896)^B1,D1^                                                  49244233                                         19315    4.9     6    40    201
   Accessory gene regulator A (AgrA)^D1^                                             14247812                                         27903    5.9     5    18    92
   DNA-directed RNA polymerase alpha chain (RpoA)^C2^                                49484440                                         34990    4.7     9    40    292
   DNA polymerase III, beta chain (DnaN)^C1,D1^                                      49482255                                         41888    4.7     8    25    194
   DNA-directed RNA polymerase delta subunit (RpoE)^C1^                              49245364                                         20868    3.6     2    14    84
   Translation elongation factor G (Fus)^A2,B2,C3,D2^                                49243855                                         76564    4.8     19   40    915
   Elongation factor TS (Tsf)^A2,B3,C3,D5^                                           14247027                                         32473    5.2     15   57    683
   Elongation factor P, putative (Efp)^D1^                                           49483778                                         20541    4.8     2    11    82
   RsbW (RsbW)^B1^                                                                   37781578                                         17896    4.7     3    20    70
   TatD related Dnase, putative (MW0446)^D1^                                         49482718                                         29263    5.1     4    17    126
   Transcription pleiotropic repressor (CodY)^B1,D2^                                 49483418                                         28737    5.9     8    35    354
   Transcription termination-anti-termination factor (NusA)^C1,D1^                   14247036                                         43729    4.6     9    29    242
   Transcriptional regulator (MW0363)^B2,D3^                                         14246155                                         15127    5.0     7    65    301
   Transcriptional regulator, LytR family (SAUSA300_0958)^D1^                        1723223                                          23880    5.7     5    33    170
   Transcriptional regulator, LytR family (MW0939)^C1,B2^                            57284435                                         45657    6.0     6    20    144
   Translation initiation factor IF-1 (InfA)^B1^                                     49484444                                         8274     6.7     2    38    64
   Translation elongation factor Tu (Tuf)^A2,B1,C2,D3^                               49243856                                         43077    4.7     16   59    871
   Transposase (MW2398)^B2,D2^                                                       49484688                                         16446    5.6     4    33    191
  Miscellaneous (13)                                                                                                                                              
   IIIG9 protein, similar to- (LOC576703)^B1^                                        72179405                                         52711    9.4     1    2     51
   6,7-Dimethyl-8-ribityllumazine synthase (RibH)^B1,D1^                             49242141                                         16412    5.7     7    73    342
   ABC transporter-associated protein, SufB (MW0799)^D1^                             49483078                                         52512    5.1     7    18    139
   Amylase (MalA)^D1^                                                                18145251                                         77435    5.9     1    1     54
   Aldo/keto reductase family protein (MW2127)^D1^                                   49482959                                         32339    5.2     4    12    114
   Arsenate reductase family protein (MW0785)^D1^                                    49483064                                         13591    6.7     3    49    133
   Lipoate synthase (LipA)[\*](#tf1-2){ref-type="table-fn"}^A1^                      27807337                                         16468    6.3     2    17    54
   Cell wall surface anchor family protein (MW2416)^C1,D1^                           57285190                                         136262   5.7     16   16    804
   Short chain dehydrogenase (MW2249)^B1^                                            14248102                                         31777    4.7     2    5     72
   Immunodominant antigen A (IsaA)^A9,B5,C13,D2^                                     14248343                                         24189    5.9     4    23    259
   N-Acetylglucosamine 6-phosphate deacetylase (NagA)^D1^                            87161324                                         43089    5.4     7    20    123
   4-Nitrophenylphosphatase-probable (MW0811)^B1^                                    82750544                                         27962    4.5     4    16    61
   SufD (SufD)^D1^                                                                   82750525                                         48518    5.4     5    18    69
  Unknown (20)                                                                                                                                                    
   Conserved hypothetical protein (SAUSA300_0871)^D1^                                88194663                                         33093    4.8     9    42    262
   Conserved hypothetical protein (SAUSA300_0916)^D1^                                88194708                                         19314    5.0     7    47    249
   Conserved hypothetical protein (SAUSA300_1856)^D2^                                88195657                                         19536    6.1     7    46    247
   Hypothetical exported protein (MW0347)^B6,D7^                                     49243694                                         21261    5.7     3    14    115
   Hypothetical exported protein (MW2606)^B1,D1^                                     82752265                                         18700    4.7     3    25    147
   Hypothetical cytosolic protein (MW0395)^C1,S^                                     14246202                                         55465    5.1     14   32    487
   Hypothetical protein (MW0542)^B1^                                                 14246355                                         29371    5.1     3    14    97
   Hypothetical protein (MW0819)^B1,D1,M^                                            49244219                                         69762    5.1     14   30    604
   Hypothetical protein (MW2068)^D1,S^                                               4126674                                          22954    5.2     10   62    369
   Hypothetical protein (SAUSA300_0408)^A1,C5,S^                                     57285506                                         56443    4.8     19   40    899
   Hypothetical protein (SAUSA300_0279)[\*\*](#tf1-3){ref-type="table-fn"}^D1,M,S^   77383233                                         24390    6.9     1    5     51
   Hypothetical protein (MW1884)^A1,M,S^                                             30043928                                         13044    9.3     2    26    99
   Hypothetical protein (MW0577)^B1,S^                                               49482843                                         18554    9.2     4    25    124
   Hypothetical cytosolic protein (MW1786)^B1,C1,D1^                                 49484087                                         13302    4.4     9    85    406
   Hypothetical protein (MW1795)^A2,B1,D2^                                           49484096                                         22344    5.3     10   58    394
   Hypothetical protein (MW2099)^B1,D1^                                              49484393                                         10000    6.1     3    45    95
   Hypothetical protein (SAUSA300 2327)^D1^                                          87161861                                         15876    4.9     7    58    336
   Hypothetical protein (SAUSA300 pUSA010004)^C1,M,S^                                87159841                                         21257    9.3     2    11    55
   Putative exported protein (MW0355)^B8,M^                                          49243745                                         56170    5.0     17   45    620
   Putative exported protein (MW1757)^D2,S^                                          49245076                                         20371    6.8     3    21    100

The Mascot search results displayed above (Entrez Protein number, MW, pI, MP, SC%, and MS/MS MOWSE score) are from the best protein match to published *S. aureus* genomes. In many instances, database searches were performed before the genome sequence of USA300 was published and the best match is to a protein from another published *S. aureus* strain. However, the Entrez Protein name indicates the name of the likely MW2 or USA300 protein. SC, sequence coverage. MP, matched peptides.

^A^MW2 supernatants from mid-exponential phase of growth.

^B^MW2 supernatants from stationary phase of growth.

^C^LAC supernatants from mid-exponential phase of growth.

^D^LAC supernatants from stationary phase of growth.

^E^Theoretical or predicted.

^L^Contains an LPXTG cell wall anchoring signal sequence.

^M^Contains probable transmembrane regions.

^S^Contains a probable N-terminal signal peptide sequence.

^1--8^Number after the letter ^A,B,C^ or ^D^ indicates number of times a protein was identified.

Best Mascot search homology was to Cathelicidin 4 \[indolicidin\] \[*Bos taurus*\].

Best Mascot search homology was to Pfl_3008 \[*Pseudomonas fluorescens PfO-1*\] (ABA74746).

Identification of CA-MRSA exoproteins associated with virulence
---------------------------------------------------------------

Twenty exoproteins (20%) identified at mid-exponential growth and 33 (15%) of those at early stationary phase of growth are known to be associated with virulence ([Fig. 1](#fig01){ref-type="fig"} and [Table 1](#tbl1){ref-type="table"}). There were essentially three subcategories of virulence determinants found in culture media. Proteases or enzymes, including aminopeptidase (PepS), aureolysin (Aur), staphylokinase (Sak), V8 protease (SspA), cysteine protease (SspB), serine protease (SplC), lipase (Lip) and Xaa-Pro dipeptidase, were produced by each strain at either phase of growth ([Fig. 1](#fig01){ref-type="fig"} and [Table 1](#tbl1){ref-type="table"}). These enzymes degrade and/or modify proteins and lipids present in the growth environment ([@b36]; [@b24]; [@b38]; [@b22]). For example, cysteine protease/staphopain B (SspB), which directly cleaves kininogen, also works in concert with staphopain A (ScpA) to promote vascular leakage and lower blood pressure, thereby facilitating septic shock ([@b38]; [@b22]). SspA causes release of cell surface fibronectin-binding protein (FnbB) and immunoglobulin G (IgG)-binding protein A (protein A, Spa), modifying capacity for host interaction and increasing free FnbB and Spa ([@b36]; [@b24]).

A second group of molecules identified in CA-MRSA culture media were those involved in bacteria--host interaction or adhesion, such as coagulase (Coa), collagen adhesin (Cna), enolase (Eno), fibrinogen-binding protein, FnbA, FnbB, 1-phosphatidylinositol phosphodiesterase (Plc), Spa and IgG-binding protein (Sbi) ([Figs 1](#fig01){ref-type="fig"} and [2](#fig02){ref-type="fig"}, and [Table 1](#tbl1){ref-type="table"}). These molecules can activate the clotting cascade (Coa) ([@b42]), mediate binding to host tissues (Cna, Eno, FnbA and FnbB) ([@b43]; [@b21]; [@b7]), and sequester host antibody (Spa and Sbi) ([@b18]; [@b54]). Although the function of *S. aureus* Plc is uncharacterized, that of *Listeria monocytogenes* promotes adhesion to epithelial cells and mediates escape of the pathogen from phagosomes ([@b28]; [@b52]).

The toxins and haemolysins, namely alpha-haemolysin (Hla), enterotoxin C3 (Sec3), enterotoxin H (Seh), enterotoxin K (Sek), enterotoxin L (Sel2) and enterotoxin Q (Seq), comprised at most 4% of the exoproteins produced by MW2 and/or LAC in mid-exponential or early stationary phases of growth (4/98 at mid-exponential phase and 6/229 at early stationary phase of growth respectively) ([Fig. 1](#fig01){ref-type="fig"} and [Table 1](#tbl1){ref-type="table"}). Unexpectedly, we failed to detect gamma-haemolysin subunits (HlgA, HlgB and HlgC), LukD/E, LukM, or either component of PVL (LukS-PV and LukF-PV) in culture supernatants under the two growth conditions tested.

Proteins involved in metabolism, biosynthesis, transcription and replication are present in MW2 and LAC culture supernatants
----------------------------------------------------------------------------------------------------------------------------

CA-MRSA culture supernatants contained 73 proteins known to be involved in the transport and utilization of carbohydrates or amino acids for energy ([Table 1](#tbl1){ref-type="table"}). Thirty-five proteins known to participate in biosynthesis of nucleotides, proteins and fatty acids, and 51 proteins involved in cell division, transcription and replication, were also identified in culture media ([Fig. 1](#fig01){ref-type="fig"} and [Table 1](#tbl1){ref-type="table"}). The observation that cytoplasmic proteins were found in culture supernatant is not unexpected, as numerous cycles of autolysis would have occurred thereby releasing proteins into culture medium ([@b30]; [@b11]; [@b47]).

Stress response proteins are present in culture supernatants
------------------------------------------------------------

Twenty proteins associated with the response to environmental stress were identified in MW2 and LAC culture supernatants ([Fig. 1](#fig01){ref-type="fig"} and [Table 1](#tbl1){ref-type="table"}). For example, alkyl hydroperoxide reductase (AhpC and AhpF), catalase (KatA), superoxide dismutase (SodA), thioredoxin (TrxA) and thioredoxin reductase (TrxB), proteins that function to inactivate reactive oxygen species, and heat shock proteins, GroES and DnaK, were identified in culture supernatants at both phases of growth ([Fig. 1](#fig01){ref-type="fig"} and [Table 1](#tbl1){ref-type="table"}). Consistent with this observation, genes encoding these proteins are induced in MW2 and LAC during phagocytosis by human neutrophils ([@b48]). Further, heat shock proteins such as DnaK and GroEL have been shown to be immunogenic in patients with *S. aureus* endocarditis ([@b44]; [@b45]), suggesting they are exoproteins *in vivo*.

MW2 and LAC produced numerous exoproteins of unknown function
-------------------------------------------------------------

We identified 20 culture supernatant proteins with no characterized function, including four putative exported proteins ([Fig. 1](#fig01){ref-type="fig"}, [Table 1](#tbl1){ref-type="table"} and Table S1) ([@b2]; [@b15]). Fourteen of these proteins were conserved across 10 sequenced strains of *S. aureus* (Table S1). Genes encoding MW0395 and MW1757 reside within Type II genomic islands of MW2 known as νSaα and νSaβ respectively, and each is located near or among putative virulence determinants ([@b2]). MW1884 is encoded by MW2 prophage ΦSa3 and is juxtaposed to the gene encoding staphylokinase (*sak*), a known virulence factor in *S. aureus* ([@b2]). Several other exoproteins with no characterized function, such as MW0542, MW1795, MW2068, SAUSA300_0871, SAUSA300_0916 and SAUSA300_2327, have homology to enzymes that participate in metabolism or replication, or respond to stress (Table S1). It will be important to determine whether some of these proteins have a role in virulence and/or if they are potential vaccine targets.

Selected MW2 and LAC exoproteins differ in abundance
----------------------------------------------------

Although MW2 and LAC produced many common exoproteins, 11 exoproteins detected at either phase of growth differed in abundance between the strains ([Figs 3](#fig03){ref-type="fig"} and [4](#fig04){ref-type="fig"}). Hla and a putative surface protein (SAUSA300_0408) were in greater abundance in LAC culture supernatants at mid-exponential growth phase, and multiple repeat polypeptide (Mrp), Sak, and Coa were found exclusively in the same supernatants ([Fig. 3A](#fig03){ref-type="fig"}). By comparison, Cna, Sec3 and a putative exported protein (MW0355) were identified as exoproteins only in MW2 culture supernatants at mid-exponential growth ([Fig. 3B](#fig03){ref-type="fig"}).

![Quantitative analysis of CA-MRSA culture supernatant proteins produced during growth *in vitro*. Differential analysis of MW2 and LAC culture supernatant proteins was performed as described under *Experimental procedures*. Proteins more abundant in/found only in LAC (A and D) or MW2 (B and E) supernatants. Panels C and F represent proteins equally abundant in MW2 and LAC. The phase of growth at which the analysis was performed is indicted to the left of the panels. Results are the mean ± SD of three separate experiments at each phase of growth.](cmi0009-1172-f3){#fig03}

![Exoproteins produced by MW2 and LAC during infection. Culture supernatant proteins made by MW2 or LAC at the indicated phase of growth were separated by 2-DGE, transferred to nitrocellulose membranes, and probed with convalescent sera from mice infected with each strain or non-immune sera (not shown). Proteins immunoreactive only with sera from infected mice are indicated (boxed). Unidentified immunoreactive proteins are annotated with Arabic numbers. Immunoblots are representative of three separate experiments.](cmi0009-1172-f4){#fig04}

At stationary phase of growth, Hla, Sak, Lip, Seq, SplC, SspA, SspB and Sek were either increased ≥ 2-fold in LAC supernatants or were found only in those supernatants ([Fig. 3D](#fig03){ref-type="fig"}). There was far more Cna (39.5-fold) in MW2 supernatants at this phase of growth, and Sec3 and MW0577, a protein of unknown function, were detected only in MW2 culture media ([Fig. 3E](#fig03){ref-type="fig"}). Differences in exoproteins between these strains may underlie in part the noted variances in disease phenotypes ([@b2]; [@b25]; [@b39]; [@b48]; [@b15]).

Exoproteins made during infection *in vivo*
-------------------------------------------

To reconcile exoproteins produced by MW2 and LAC *in vitro* and those made during infection *in vivo*, we used a mouse abscess model to generate immune/convalescent sera from mice infected with MW2 and LAC ([@b49]). Following 2-DGE and transfer to nitrocellulose, MW2 and LAC exoproteins were probed with convalescent serum from mice infected with either MW2 or LAC. Several proteins from these CA-MRSA strains were commonly immunogenic in mice ([Fig. 4](#fig04){ref-type="fig"}). For example, AhpC, Atl, formate tetrahydrofolate ligase (Fhs), glyceraldehyde 3-phosphate dehydrogenase (Gap), Lip and SspB were immunogenic in mice infected with either strain ([Fig. 4](#fig04){ref-type="fig"} and [Table 2](#tbl2){ref-type="table"}). Cna, Sec3 and Sak are known virulence factors that were immunogenic in mice infected with either MW2 (Cna and Sec3) or LAC (Sak) ([Fig. 4](#fig04){ref-type="fig"} and [Table 2](#tbl2){ref-type="table"}), findings consistent with the differential analysis of exoproteins produced *in vitro* (compare [Figs 3](#fig03){ref-type="fig"} and [4](#fig04){ref-type="fig"}). Although many other immunogenic proteins were detected by our analysis, many were cross-reactive with non-immune sera (unboxed, unmarked protein spots, [Fig. 4](#fig04){ref-type="fig"}) or could not be identified with absolute certainty (indicated by numbers, [Fig. 4](#fig04){ref-type="fig"}). Taken together, these data provide strong support to the idea that proven or putative virulence factors, such as Atl, Cna, Lip, Sak, Sec3 and SspB, are made during CA-MRSA infection *in vivo*.

###### 

Immunogenic (*in vivo* expressed) exoproteins of MW2 and LAC.

  Protein[a](#tf2-1){ref-type="table-fn"}         MW2     LAC     Immunoreactivity
  ----------------------------------------------- ------- ------- ------------------
  AhpC, alkyl hydroperoxide reductase             ME, S   ME, S   NI, I
  AroA, chorismate mutase                         --      S       I
  Asp23, alkaline shock protein 23                --      S       NI, I
  Atl, autolysin                                  ME, S   ME, S   I
  ClpP, ATP-dependent Clp protease                S       S       NI, I
  Cna, collagen adhesin precursor                 ME, S   --      I
  Coa, coagulase                                  ME      --      NI, I
  DeoD, purine nucleoside phosphorylase           ME      ME      NI, I
  Ear                                             S       S       I
  Eno, enolase                                    S       S       NI, I
  Fba, fructose bisphosphate aldolase             S       --      NI, I
  Fhs, formate tetrahydrofolate ligase            ME, S   ME, S   I
  Ftn, ferritin                                   --      S       I
  Gap, glyceraldehyde 3-phosphate dehydrogenase   ME, S   ME, S   I
  GlyA, serine hydroxymethyltransferase           --      S       I
  Gpi, glucose 6-phosphate isomerase              ME      ME      NI, I
  GuaB, inositol-monophosphate dehydrogenase      ME      --      NI, I
  Idh1, isocitrate dehydrogenase                  --      S       NI, I
  Lip, lipase                                     S       S       I
  MW0525, hexulose 6-phosphate synthase           --      S       I
  MW0896, 2′−5′ RNA ligase                        --      S       NI, I
  MW1795, hypothetical protein                    --      S       NI, I
  MW1870, thioredoxin                             --      S       NI, I
  PdhA, pyruvate dehydrogenase subunit A          ME      ME      NI, I
  PdhB, pyruvate dehydrogenase subunit B          S       S       NI, I
  Pgd, phosphogluconate dehydrogenase             ME      ME      NI, I
  Pgi, phosphoglucose isomerase                   S       S       NI, I
  Plc, 1-phosphatidylinositol phosphodiesterase   S       S       I
  Pta, phosphate acetyltransferase                --      S       I
  RocD, ornithine aminotransferase                S       --      NI, I
  Sak, staphylokinase                             ME      ME, S   I
  Sec3, staphylococcal enterotoxin C3             S       --      I
  Seq, staphylococcal enterotoxin Q               ME      ME      I
  SodA, superoxide dismutase                      S       S       I
  Spa, immunoglobulin-binding protein A           ME, S   ME, S   NI, I
  SspB, cysteine protease precursor               ME, S   ME, S   I
  Sulfatase                                       S       --      NI, I
  Tkt, transketolase                              S       --      I
  TpiA, triosephosphate isomerase                 --      ME      I
  Tsf, translation elongation factor Ts           ME      S       I
  Tuf, translation elongation factor Tu           ME, S   ME, S   NI, I
  Unknown 1                                       ME      --      I
  Unknown 2                                       ME      --      I
  Unknown 3                                       --      ME      I
  Unknown 4                                       --      ME      I
  Unknown 5                                       --      ME      I
  Unknown 6                                       --      ME      I

Protein identities were obtained by overlay analysis as described under *Experimental procedures*. Results are representative of three experiments using serum pooled from 10 to 15 mice.

ME, mid-exponential phase of growth; S, stationary phase of growth; NI, non-immune sera; I, immune sera.

Phagocytosis of CA-MRSA by human neutrophils triggers production/secretion of virulence factors
-----------------------------------------------------------------------------------------------

To determine if production of selected exoproteins is triggered by interaction of *S. aureus* with host cells and/or if the proteins are made within phagosomes, we used confocal laser-scanning microscopy to evaluate production of Aur, Hla, SspA and SspB after phagocytosis by human polymorphonuclear leucocytes (PMNs) ([Figs 5](#fig05){ref-type="fig"} and [6](#fig06){ref-type="fig"}). Notably, there was a time-dependent increase in Aur, Hla, SspA and SspB produced by MW2 and/or LAC within neutrophil phagocytic vacuoles ([Figs 5](#fig05){ref-type="fig"} and [6](#fig06){ref-type="fig"}, yellow arrowheads). There was also redistribution of each molecule over time; at 15 or 60 min proteins were typically localized only to *S. aureus*, whereas at 3 or 4 h after phagocytosis each molecule was diffused within larger, more mature phagosomes or distributed throughout the cell ([Figs 5](#fig05){ref-type="fig"} and [6](#fig06){ref-type="fig"}, yellow arrowheads). Accumulation of these molecules late during phagocytosis correlates well with the noted PMN lysis caused by MW2 and LAC ([Figs 5](#fig05){ref-type="fig"} and [6](#fig06){ref-type="fig"}) ([@b48]). Production of virulence factors within phagosomes is consistent with the notion that these proteins are made during infection *in vivo*.

![Production and distribution of selected MW2 (USA400) virulence factors during phagocytosis by human PMNs. Following phagocytosis of MW2, aureolysin (Aur), SspA and SspB were visualized by confocal laser-scanning microscopy. White arrowheads indicate bacteria. Yellow arrowheads indicate areas enriched with the *S. aureus* protein of interest. The image labelled 'Merge' illustrates distribution of neutrophil actin-related protein (ARP, green) and nuclei (blue). DIC, differential interference contrast.](cmi0009-1172-f5){#fig05}

![Production and distribution of selected LAC (USA300) virulence factors during phagocytosis by human PMNs. Following phagocytosis of LAC, Hla, SspA and SspB were visualized by confocal laser-scanning microscopy. Labelling for this figure is otherwise identical to the legend for [Fig. 5](#fig05){ref-type="fig"}.](cmi0009-1172-f6){#fig06}

Discussion
==========

The striking increase in CA-MRSA infections over the past few years has prompted an intense search for the underlying molecular determinants. To date, few virulence factors are associated specifically with CA-MRSA disease and no single determinant appears to account for the increased incidence and severity of CA-MRSA infections ([@b31]; [@b2]; [@b3]; [@b14]; [@b15]; [@b20]; [@b49]). It is almost certain that a combination of virulence determinants, including *S. aureus* exoproteins, and host susceptibility promote disease in otherwise healthy subjects. Inasmuch as exoproteins produced by CA-MRSA probably facilitate evasion of innate host defence ([@b48]) and thereby contribute to disease, we performed a comprehensive analysis of exoproteins produced by MW2 and LAC *in vitro* and during infection.

A limited number of proteomics-based studies have investigated exoproteins of *S. aureus*, typically using strain COL or laboratory-derived strains ([@b55]; [@b56]; [@b40]). For example, Ziebrandt *et al*. recently compared *S. aureus* strains RN6390 and RN6911 and identified 43 exoproteins produced *in vitro*, including many controlled by accessory gene regulator (*agr*) and/or alternative sigma factor ó^B^ (*sigB*) ([@b56]). Nakano *et al*. identified 29 exoproteins produced by MRSA strains using 2-DGE coupled with N-terminal peptide sequencing ([@b40]). By comparison, numerous studies have reported individual *S. aureus* exoproteins that promote pathogenesis, including proteases ([@b36]; [@b24]; [@b22]), enterotoxins and exotoxins ([@b16]; [@b34]), and leukotoxins and haemolysins ([@b23]). Although progress has been made towards identification and characterization of many important *S. aureus* exoproteins, there is a noted paucity of information regarding exoproteins produced by CA-MRSA strains.

Our analysis of MW2 (USA400) and LAC (USA300) culture supernatants identified 250 exoproteins (out of 600+ resolved protein spots) between two phases of growth *in vitro*, at present the single most comprehensive view of *S. aureus* exoproteins. Differential analysis of MW2 and LAC exoproteins revealed key differences between the strains ([Fig. 3](#fig03){ref-type="fig"}). These differences were not due to differences in rate of growth between the strains, because MW2 and LAC have essentially identical growth curves *in vitro* ([Fig. 1A](#fig01){ref-type="fig"}). Although many of the differentially abundant exoproteins, including Atl, Coa, Hla, Lip, Mrp, Sak, Sek, Seq, Sec3, SspA, SspB and SplC, are relatively ubiquitous among *S. aureus*, it is possible that the observed variances in protein levels relate to distinct strain pathologies. For example, Cna is linked to necrotizing pneumonia ([@b3]) and there were higher levels of this exoprotein in MW2 culture supernatants ([Fig. 3](#fig03){ref-type="fig"}). MW2 is a strain known to cause lethal pneumonia ([@b8]). Compared with MW2, more Hla was present in LAC culture supernatants (7.5 ± 1.8- and 9.2 ± 1.8-fold more Hla at mid-exponential and stationary phases of growth respectively). Consistent with that observation, Hla appeared to accumulate more rapidly in LAC-containing neutrophil phagosomes or was more highly diffused in and around deteriorating PMNs after phagocytosis of LAC compared with MW2 containing cells (accumulation of Hla typically occurred by 180 min in LAC-containing PMNs versus 240 min in those with MW2). We recently found dramatic differences in pathophysiology between MW2 and LAC in a mouse skin infection/abscess model ([@b49]). LAC produced rapid and pronounced dermonecrosis in infected animals, whereas mice infected with MW2 developed intact abscesses ([@b49]). Thus, differences in exoprotein abundance, such as that for Hla, may underlie the differences in strain pathology. Additional studies are needed to test this hypothesis.

We used sera from mice infected with MW2 or LAC to identify exoproteins made during infection *in vivo* ([Fig. 4](#fig04){ref-type="fig"}). Previous serological proteome studies using strain COL identified 15 immunogenic proteins made during human infections, although only four of these proteins (alkaline shock protein, hexose 6-phosphate synthase, PdhB and Tuf) are common with our analysis ([Table 2](#tbl2){ref-type="table"}) ([@b50]). In more recent work, Clarke *et al*. used bacteriophage expression libraries to identify *S. aureus* antigens produced during human infections ([@b12]). Several of those immunogenic proteins, i.e. chorismate mutase (AroA), autolysin (Atl), Coa, Fhs, Gap, transketolase (Tkt) and triosephosphate isomerase (Tpi), were also identified as *in vivo* expressed *S. aureus* antigens by our studies ([Table 2](#tbl2){ref-type="table"}). Our work revealed many additional exoproteins produced during infection, such as AhpC, Cna, Ear, ferritin (Ftn), Lip, Plc, phosphate acetyltransferase (Pta), Sak, Sec3, Seq and SspB ([Fig. 4](#fig04){ref-type="fig"}). Importantly, these proteins were immunoreactive only with sera from MW2- or LAC-infected animals (as opposed to sera from uninfected animals). Variances in antigenic exoproteins between MW2 and LAC are likely explained in part by differences in gene content or phase of growth used to test antigenicity ([Fig. 4](#fig04){ref-type="fig"}). The relative importance of these *in vivo* expressed proteins remains to be determined.

At least four of the exoproteins identified by our proteomic analysis (Aur, Hla, SspA and SspB) were produced within phagosomes of human neutrophils following uptake (phagocytosis) ([Figs 5](#fig05){ref-type="fig"} and [6](#fig06){ref-type="fig"}). These findings are notable because MW2 and LAC are known to cause rapid lysis of PMNs ([@b48]) and the factors responsible for the dramatic host cell lysis remain elusive ([@b49]). Consistent with these data, we determined previously that the gene encoding Hla was upregulated during phagocytosis ([@b48]). Although our studies do not demonstrate that Aur, Hla, SspA and SspB are directly related to the observed PMN lysis, increased accumulation of these virulence determinants accompanied initial stages of neutrophil destruction ([Figs 5](#fig05){ref-type="fig"} and [6](#fig06){ref-type="fig"}).

The *S. aureus* genome consists of ∼2600 proteins of which more than 40% have no similarity to proteins of known function ([@b29]). Moreover, 33% of identified proteins are unique to *S. aureus* ([@b29]). Therefore, it is not surprising that 8.5% of the proteins identified in our study have no known function ([Fig. 1](#fig01){ref-type="fig"}). Some of these exoproteins are of significant interest based upon homology to known *S. aureus* proteins (e.g. SAUSA300_0407 as an exotoxin homologue) or given their location within the genome ([Table 1](#tbl1){ref-type="table"} and Table S1). Several exoproteins identified by our analysis are putative exported or surface proteins, e.g. SAUSA300_0408 and MW0355 (rather than metabolism enzymes, etc.) and also require characterization in the context of CA-MRSA pathogenesis ([Fig. 3](#fig03){ref-type="fig"}).

We used a proteomics-based approach to generate a comprehensive view of exoproteins made by prominent CA-MRSA strains, including identification of proteins that are immunogenic and thus produced during infection *in vivo*. Identification of these exoproteins is an important first step towards development of vaccines, prophylactics, and enhanced therapeutics designed to control CA-MRSA infections.

Experimental procedures
=======================

Growth of *S. aureus* and generation of culture supernatants
------------------------------------------------------------

*Staphylococcus aureus* strains MW2 (USA400) ([@b2]) and LAC (USA300-0114) ([@b25]; [@b39]; [@b48]; [@b15]) were cultured in tryptic soy broth containing 0.25% dextrose (TSB, Becton, Dickenson, and Company, Franklin Lakes, NJ) filtered sequentially through 10 kDa cut-off and 0.22 μm filters. Cultures were inoculated with a 1:200 dilution of overnight culture (500 μl of culture into 100 ml of TSB in a 1 l flask) and incubated at 37°C with shaking (250 rpm). All strains were cultured to mid-exponential (OD~600~ = 0.75) or stationary (OD~600~ = 2.0) phases of growth and placed on ice until used. Bacteria were removed from culture media by two sequential rounds of centrifugation at 2851 *g* for 10 min at 4°C. This procedure yielded clarified culture supernatants for subsequent proteomic analyses.

Precipitation and preparation of culture supernatant proteins
-------------------------------------------------------------

Precipitation of proteins from clarified culture supernatants was performed in polypropylene flasks to reduce protein loss. One hundred millilitres of clarified supernatant was added to 300 ml of 100% ethanol (Molecular Grade, Sigma-Aldrich, St Louis, MO) and chilled at −20°C overnight. Precipitated protein was transferred to Oakridge centrifuge tubes and sedimented by centrifugation at 27 216 *g* for 30 min at 4°C. To optimize yield, protein in polypropylene flasks (residual) and centrifuge tubes was air-dried for approximately 1 h. Protein in the flasks were solubilized with 3 ml of 2-D solubilization solution (7 M urea, 2 M thiourea, 4% CHAPS) with gentle swirling. These samples were transferred to Oakridge tubes containing precipitated protein pellets and swirled gently to dissolve pellets. Polypropylene flasks were rinsed with an additional 600 μl of 2-D solubilization solution.

Culture supernatant proteins were clarified further with a second precipitation in 30% trifluoroacetic acid (Sigma-Aldrich) and incubated on ice for a minimum of 30 min. Precipitated proteins were collected by centrifugation at 14 100 *g* for 5 min at room temperature. The protein pellet was dispersed by vortexing in 25 μl of distilled H~2~O for 10 s followed by the addition of 1 ml of acetone (−20°C). Proteins were washed in acetone for a minimum of 30 min at −20°C and then pelleted by centrifugation at 14 100 *g* for 5 min at room temperature. Proteins were air dried for ∼1 h or until pellets appeared dry. Pellets were solubilized in 400 μl of Destreak Rehydration Solution (GE Healthcare, Piscataway, NJ) containing tributylphosphine (200 mM) and ampholytes (pH 3--10, 4 μl of 100× solution) (Bio-Rad, Hercules, CA) at room temperature for 1 h with constant swirling. Samples were used immediately or stored briefly at −20°C.

Isolation of human neutrophils
------------------------------

Human polymorphonuclear leucocytes were isolated from fresh venous blood of healthy individuals using a published method ([@b26]; [@b6]). Studies were performed in accordance with a protocol approved by the Institutional Review Board for Human Subjects, National Institute of Allergy and Infectious Diseases. PMN preparations typically contained ∼94% neutrophils, with the remaining cells being predominantly eosinophils. All reagents used contained \< 25.0 pg ml^−1^ endotoxin (Limulus Amebocyte Lysate assay, Fisher Scientific, Suwannee, GA).

Neutrophil phagocytosis
-----------------------

MW2 and LAC were cultured to mid-exponential phase of growth and phagocytosis experiments were performed with serum-opsonized bacteria as described ([@b27]; [@b48]). At the indicated times, phagocytosis was terminated either by chilling PMNs on ice or adding cold paraformaldehyde (4%) to assay wells.

Generation of immune sera
-------------------------

Female Crl:SKH1-hrBR mice (Charles River Laboratories, Wilmington, MA) were anaesthetized with isoflurane and inoculated with 50 μl of DPBS containing 10^7^ cfu of MW2 or LAC by subcutaneous injection in the right flank. Abscesses typically formed within 4 days and resolved 14 days after infection ([@b49]). At 28 days post infection, mice were euthanized and blood was collected from 10 to 15 mice to prepare pooled immune serum. Blood from uninfected animals was processed in parallel (non-immune serum). All studies conformed to guidelines set forth by the National Institutes of Health and were reviewed and approved by the Animal Use Committee at Rocky Mountain Laboratories, NIAID.

Isoelectric focusing and second-dimension SDS-PAGE
--------------------------------------------------

Culture supernatant proteins were precipitated in cold acetone and then solubilized with isoelectric focusing (IEF) buffer (7% urea, 2% thiourea, 4% CHAPS and 200 mM tributylphosphine) as described ([@b6]). Protein concentration was measured with the 2-D Quant kit (GE Healthcare) and purified proteins were stored at −80°C.

For IEF, samples were treated with Destreak Rehydration solution (25% of total sample volume) (GE Healthcare), 200 mM tributylphosphine and 1% ampholytes. IEF was performed with 11 cm IPG Ready Strips for 40 kVh. IPG Ready Strips were rehydrated actively at 50 V overnight prior to first dimension separation. Moistened filter paper wicks (Whatman no. 1 paper, Whatman, Florham Park, NJ) were added between each electrode and strip prior to focusing (after rehydration). Wicks were changed four times in the first 4 h of IEF, after which the voltage was maintained at 8000 V (11 cm IPG Ready Strips). Following IEF, IPG Ready Strips were stored at −80°C until used for SDS-PAGE.

Second-dimension SDS-PAGE was performed essentially as described ([@b6]), except electrophoresis was performed at 50 mA per gel until the dye front reached the bottom of each gel (∼1 h for 11 cm gels). Protein spots were excised and peptides were prepared for ADI-MS/MS analysis as described previously for liquid chromatography-tandem mass spectrometry (LC-MS/MS) ([@b6]). For simplicity, the combination of IEF and second-dimension SDS-PAGE is abbreviated as 2-DGE.

Mass spectrometry
-----------------

Peptide samples (tryptic digests, as described/referenced above) were analysed by automated direct infusion (ADI) using Nanomate (Advion BioSciences, Ithaca, NY), an automated chip-based nano-electrospray interface source, coupled to a quadrupole-time of flight mass spectrometer, QStarXL MS/MS System (Applied Biosystems/Sciex, Framingham, MA). Computer-controlled data-dependent automated switching to MS/MS provided peptide sequence information. AnalystQS software (Applied Biosystems/Sciex) was used for data acquisition. Data processing and databank searching were performed with Mascot software version 2.1 (Matrix Science, Beachwood, OH). The National Center for Biotechnology Information non-redundant protein database (NCBInr, updated 12 May, 2006 at 18:01:48 GMT), National Library of Medicine, NIH was used for the search analysis. Search criteria were limited to double- and triple-charge ions and included monoisotopic masses, analysis of peptides for carbamidomethylation and/or propionamidylation of cysteine, oxidation of methionine, peptide and MS/MS tolerances of 0.2 Da and 0.8 Da respectively, and a maximum of one missed tryptic cleavage. Significance threshold for positive identification was determined by the Mascot Search program.

Amino acid sequence analysis
----------------------------

Proteins involved in virulence/defence mechanisms, stress response proteins, toxins, haemolysins and proteins of unknown function were evaluated for presence of an LPXTG motif, which predicts a cell wall anchor, and/or for sequences that predict an N-terminal signal peptide or transmembrane region(s). We used the NCBInr database to query the full sequence of each protein identified by ADI/MS/MS for the presence of LPXTG motifs. The presence of membrane spanning domains and N-terminal signal peptide sequences was deduced by searching protein sequences with PSORT software provided by the PSORT WWW server (<http://psort.nibb.ac.jp/>). Although none of the 20 hypothetical proteins identified in this study contain LPXTG motifs, eight proteins contain probable N-terminal signal peptide sequences and five have predicted transmembrane regions ([Table 1](#tbl1){ref-type="table"} and Table S1).

In addition, sequences of the hypothetical proteins were compared to 902 genomes (Bacterial, Archaea, Viral, and Eukarya) using NCBI and ERGO, a curated NIAID database containing public and proprietary DNA.

SDS-PAGE and immunoblotting
---------------------------

Proteins were separated by SDS-PAGE, transferred to nitrocellulose membranes, and membranes were blocked with 10% normal goat serum in Tris buffered saline 150 mM NaCL, 50 mM Tris base, pH 7.5, 1% Tween 20 and 0.02% sodium azide (Sigma-Aldrich) overnight at 4°C. Blots were probed with immune or non-immune mouse sera for 1--2 h at ambient temperature or overnight at 4°C. Blots were washed in buffer containing 250 mM NaCl, 10 mM Hepes and 2% Tween 20 (Sigma-Aldrich) and incubated with secondary antibodies conjugated to horseradish peroxidase for 1--2 h at ambient temperature. Immunoreactive proteins were visualized with enhanced chemiluminescence (SuperSignal West Pico, Pierce Biotechnology, Rockford, IL) using Kodak X-Omat film (Eastman Kodak, Rochester, NY).

Immunofluorescence and confocal laser-scanning microscopy
---------------------------------------------------------

Acid washed coverslips (No. 1, 13 mm, round) were flamed and coated with 100% normal human serum in 24 well tissue culture plates for 1 h. Coverslips were washed twice with DPBS and synchronized phagocytosis was performed in 24 well plates as described above. Fixed PMNs were washed three times in DPBS and then permeabilized with 0.2% Triton X-100 for 5 min. After three more washes in DPBS, cells were incubated with blocking buffer (DPBS containing 5% BSA, 0.02% sodium azide) for 1 h. Samples were labelled with a 1:1000 dilution of rabbit antiserum containing antibodies specific for Hla (Sigma-Aldrich), SspA, SspB, Aur and 2 μg ml^−1^ of goat polyclonal antibodies specific for human actin-related protein 2 μg ml^−1^ (Santa Cruz Biotechnologies, Santa Cruz, CA) overnight at 4°C. Samples were washed and subsequently labelled with donkey anti-rabbit antibody conjugated with phycoerythrin 1:1000 (Jackson Immunoresearch, West Grove, PA) or donkey anti-goat antibody conjugated to AlexaFluor488 (1:1000) (Molecular Probes, Eugene, OR). PMNs were stained with DAPI (300 nM in DPBS, Molecular Probes) and DRAQ5 (1.25 μM in DPBS, Biostatus Limited, Leicestershire, UK) prior to mounting coverslips onto slides. Slides were analysed with a Zeiss LSM510 confocal laser-scanning microscope coupled to an Axiovert 200M inverted microscope (Carl Zeiss, Thornwood, NY). Images were acquired using a 100× Plan-Apochromat oil immersion objective (1.4 NA) at 512 × 512 pixel resolution with 2.7× digital magnification. Images were adjusted equally for brightness and contrast in Adobe Photoshop CS (Adobe Systems Incorporated, San Jose, CA).
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